RecruitingPhase 3NCT07789743
Rare condition
African trypanosomiasis
1
studies recruiting now
as of 7 Sept 2026
32
studies registered in total
as of 7 Sept 2026
1
countries with a recruiting site
as of 7 Sept 2026
27 Aug 2026
most recent study posted
among recruiting studies
Recruiting trials
Showing the 1 most recently updated recruiting study, as recorded 7 Sept 2026. Live status on each study page.
Search all African trypanosomiasis studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new African trypanosomiasis study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About African trypanosomiasis
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
3 approved treatments and 3 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Eflornithine, (S)-Approved: EflornithineApproved: Fexinidazole
Phase 2/3Nifurtimox (Lampit)
Phase 2/3Acoziborole
Phase 1Suramin
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).